Targeting cMET with INC280 impairs tumour growth and improves efficacy of gemcitabine in a pancreatic cancer model

BACKGROUND: Expression and activation of the cMET receptor have been implicated in tumor progression and resistance to chemotherapy in human pancreatic cancer. In this regard we assessed the effects of targeting cMET in pancreatic cancer models in vitro and in vivo. METHODS: Human (L3.6pl, BxP3, HPA...

Descripción completa

Detalles Bibliográficos
Autores principales: Brandes, Franziska, Schmidt, Katharina, Wagner, Christine, Redekopf, Julia, Schlitt, Hans Jürgen, Geissler, Edward Kenneth, Lang, Sven Arke
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4340491/
https://www.ncbi.nlm.nih.gov/pubmed/25884642
http://dx.doi.org/10.1186/s12885-015-1064-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4340491/
https://www.ncbi.nlm.nih.gov/pubmed/25884642
http://dx.doi.org/10.1186/s12885-015-1064-9

Ejemplares similares